PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy

Completed · Phase 2

Conditions studied: Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer

In brief

RATIONALE: PET scans done during chemotherapy may help doctors assess a patient's response to treatment and help plan the best treatment. PURPOSE: This randomized phase II trial is studying PET scan imaging in assessing response in patients with esophageal cancer receiving combination chemotherapy.

Key facts

Study ID
NCT01333033
Run by
Alliance for Clinical Trials in Oncology
People needed
257
Starts
2011-07-01
Expected to finish
2023-04-01
Last updated by the study team
2023-04-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.